[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:central-nervous-system-sarcoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":27,"states":28},"Central Nervous System Sarcoma",3,[7,15,21],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07017816","A Phase 0\u002F1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.",[11],"Early Phase 1","RECRUITING","2026-08-26T02:17:32.059863Z","2026-05-05T02:43:27.319544Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05697874","International Rare Brain Tumor Registry",[],"2026-08-26T02:16:05.813655Z","2026-05-13T02:55:06.371171Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT01247597","DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study",[],"2026-08-26T02:16:02.918558Z","2026-07-05T05:32:16.769834Z",[],[]]